Denovogen

Denovogen revolutionize minimally invasive treatments in surgical oncology. By leveraging advances in cancer therapeutics, imaging technology and computer vision, we are building a semi-autonomous robotic platform that allows physicians to remove tumours with unprecedented accuracy and precision, while sparing as much healthy tissue as possible. The first application of our technology is to treat primary and secondary liver tumours, enabling physicians to deliver the best quality of care to their patients.

founder

Radu Alexandru Paun

number of employees

1

Place

Montréal (Qc) Canada